276 related articles for article (PubMed ID: 9573100)
1. Cloning of Syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral leishmaniasis.
Melby PC; Tryon VV; Chandrasekar B; Freeman GL
Infect Immun; 1998 May; 66(5):2135-42. PubMed ID: 9573100
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional profiling of the spleen in progressive visceral leishmaniasis reveals mixed expression of type 1 and type 2 cytokine-responsive genes.
Espitia CM; Saldarriaga OA; Travi BL; Osorio EY; Hernandez A; Band M; Patel MJ; Medina AA; Cappello M; Pekosz A; Melby PC
BMC Immunol; 2014 Nov; 15():38. PubMed ID: 25424735
[TBL] [Abstract][Full Text] [Related]
3. The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response.
Melby PC; Chandrasekar B; Zhao W; Coe JE
J Immunol; 2001 Feb; 166(3):1912-20. PubMed ID: 11160239
[TBL] [Abstract][Full Text] [Related]
4. Real-time reverse transcription-PCR quantification of cytokine mRNA expression in golden Syrian hamster infected with Leishmania infantum and treated with a new amphotericin B formulation.
Rama Iñiguez S; Dea-Ayuela MA; Sanchez-Brunete JA; Torrado JJ; Alunda JM; Bolas-Fernández F
Antimicrob Agents Chemother; 2006 Apr; 50(4):1195-201. PubMed ID: 16569829
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional Profiling in Experimental Visceral Leishmaniasis Reveals a Broad Splenic Inflammatory Environment that Conditions Macrophages toward a Disease-Promoting Phenotype.
Kong F; Saldarriaga OA; Spratt H; Osorio EY; Travi BL; Luxon BA; Melby PC
PLoS Pathog; 2017 Jan; 13(1):e1006165. PubMed ID: 28141856
[TBL] [Abstract][Full Text] [Related]
6. Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge.
Kushawaha PK; Gupta R; Sundar S; Sahasrabuddhe AA; Dube A
J Immunol; 2011 Dec; 187(12):6417-27. PubMed ID: 22079980
[TBL] [Abstract][Full Text] [Related]
7. Comparison Between Immuno-Clinicopathological Features of Experimental and Human Visceral Leishmaniasis by Leishmania donovani.
Saini S; Dube A; Sahasrabuddhe AA; Thakur CP; Joshi S; Rawat K; Rai AK
Acta Parasitol; 2020 Mar; 65(1):57-67. PubMed ID: 31578670
[TBL] [Abstract][Full Text] [Related]
8. Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani.
Melby PC; Yang YZ; Cheng J; Zhao W
Infect Immun; 1998 Jan; 66(1):18-27. PubMed ID: 9423834
[TBL] [Abstract][Full Text] [Related]
9. Development of real-time PCR assays for evaluation of immune response and parasite load in golden hamster (Mesocricetus auratus) infected by Leishmania (Viannia) braziliensis.
Ribeiro-Romão RP; Saavedra AF; Da-Cruz AM; Pinto EF; Moreira OC
Parasit Vectors; 2016 Jun; 9(1):361. PubMed ID: 27350537
[TBL] [Abstract][Full Text] [Related]
10. Duplex real-time reverse transcriptase PCR to determine cytokine mRNA expression in a hamster model of New World cutaneous leishmaniasis.
Espitia CM; Zhao W; Saldarriaga O; Osorio Y; Harrison LM; Cappello M; Travi BL; Melby PC
BMC Immunol; 2010 Jun; 11():31. PubMed ID: 20569429
[TBL] [Abstract][Full Text] [Related]
11. Cloning and sequence analysis of Peromyscus yucatanicus (Rodentia) Th1 (IL-12p35, IFN-γ and TNF) and Th2 (IL-4, IL-10 and TGF-β) cytokines.
Loria-Cervera EN; Sosa-Bibiano EI; Villanueva-Lizama LE; Van Wynsberghe NR; Schountz T; Andrade-Narvaez FJ
Cytokine; 2014 Jan; 65(1):48-55. PubMed ID: 24120849
[TBL] [Abstract][Full Text] [Related]
12. Establishment of monoclonal antibodies to evaluate the cellular immunity in a hamster model of L infantum infection.
Carvalho LM; de Brito RCF; Gusmão MR; de Oliveira Aguiar-Soares RD; Reis AB; Roatt BM
Parasite Immunol; 2021 Apr; 43(4):e12823. PubMed ID: 33484621
[TBL] [Abstract][Full Text] [Related]
13. Splenic CD4+ T Cells in Progressive Visceral Leishmaniasis Show a Mixed Effector-Regulatory Phenotype and Impair Macrophage Effector Function through Inhibitory Receptor Expression.
Medina-Colorado AA; Osorio EY; Saldarriaga OA; Travi BL; Kong F; Spratt H; Soong L; Melby PC
PLoS One; 2017; 12(1):e0169496. PubMed ID: 28103263
[TBL] [Abstract][Full Text] [Related]
14. Imaging visceral leishmaniasis in real time with golden hamster model: Monitoring the parasite burden and hamster transcripts to further characterize the immunological responses of the host.
Rouault E; Lecoeur H; Meriem AB; Minoprio P; Goyard S; Lang T
Parasitol Int; 2017 Feb; 66(1):933-939. PubMed ID: 27794505
[TBL] [Abstract][Full Text] [Related]
15. Progressive visceral leishmaniasis is driven by dominant parasite-induced STAT6 activation and STAT6-dependent host arginase 1 expression.
Osorio EY; Zhao W; Espitia C; Saldarriaga O; Hawel L; Byus CV; Travi BL; Melby PC
PLoS Pathog; 2012 Jan; 8(1):e1002417. PubMed ID: 22275864
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 alters T helper cytokines, interleukin-12 and interleukin-18 responses to the protozoan parasite Leishmania donovani.
Wolday D; Berhe N; Britton S; Akuffo H
AIDS; 2000 May; 14(8):921-9. PubMed ID: 10853973
[TBL] [Abstract][Full Text] [Related]
17. Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis.
Miralles GD; Stoeckle MY; McDermott DF; Finkelman FD; Murray HW
Infect Immun; 1994 Mar; 62(3):1058-63. PubMed ID: 8112840
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Leishmania donovani-infected hamsters with miltefosine: analysis of cytokine mRNA expression by real-time PCR, lymphoproliferation, nitrite production and antibody responses.
Gupta R; Kushawaha PK; Samant M; Jaiswal AK; Baharia RK; Dube A
J Antimicrob Chemother; 2012 Feb; 67(2):440-3. PubMed ID: 22121191
[TBL] [Abstract][Full Text] [Related]
19. Leishmania donovani: dynamics of L. donovani evasion of innate immune cell attack due to malnutrition in visceral leishmaniasis.
Kumar V; Bimal S; Singh SK; Chaudhary R; Das S; Lal C; Pandey K; Das VR; Das P
Nutrition; 2014 Apr; 30(4):449-58. PubMed ID: 24607302
[TBL] [Abstract][Full Text] [Related]
20. Reduced nitric oxide synthase 2 (NOS2) promoter activity in the Syrian hamster renders the animal functionally deficient in NOS2 activity and unable to control an intracellular pathogen.
Perez LE; Chandrasekar B; Saldarriaga OA; Zhao W; Arteaga LT; Travi BL; Melby PC
J Immunol; 2006 May; 176(9):5519-28. PubMed ID: 16622021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
